Martin Ugander's Avatar

Martin Ugander

@mugander.bsky.social

Physician-scientist, Professor of Cardiac Imaging, U of Sydney, Founder of aecgs.com ๐Ÿ‡ฆ๐Ÿ‡บ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ธ๐Ÿ‡ช Posts about ๐Ÿซ€ imaging ๐Ÿงฒ๐Ÿ”Š โบ โ˜ข๏ธ &โšก๏ธECG #CardioSky #RadSky www.ugander.com/martin

689 Followers  |  384 Following  |  65 Posts  |  Joined: 13.11.2024  |  2.0404

Latest posts by mugander.bsky.social on Bluesky

Post image

Accuracy of #AI based measurements on echocardiography www.jacc.org/doi/10.1016/... #cardiosky @jaccjournals.bsky.social

23.09.2025 18:14 โ€” ๐Ÿ‘ 0    ๐Ÿ” 2    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Workin... Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Workin...

More about likelihood ratios in diagnostic testing:

Jaeschke R, et al, JAMA, 1994.
www.pubmed.gov/8309035

19.09.2025 01:15 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

Interpretation for both LR+ and ILR- in terms of how conclusive the test changes pretest to posttest likelihood of a positive (or negative) finding:

>10 = large
5-10 = moderate
2-5 = small but sometimes important
<2 = inconclusive

19.09.2025 01:15 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0

Inverse negative likelihood ratio (ILR-) = 1/LR- = specificity / (1-sensitivity) = 92.3% / (1-41.2%) = 1.6 = how many more times likely it is that you do NOT have the disease in question thanks to the test

19.09.2025 01:15 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0

Positive likelihood ratio (LR+) = sensitivity / (1-specificity) = 41.2% / (1-92.3%) = 5.4 = how many more times likely it is that you have the disease in question thanks to the test

19.09.2025 01:15 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0

However, sens and spec values are highly dependent on disease prevalence in the population being studied. The measures of test performance that are independent of population disease prevalence are likelihood ratios, which tell us how many times more likely a diagnosis is after applying a test.

19.09.2025 01:15 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0

In Appleโ€™s white paper on their Hypertension Notification Feature for Apple Watch, they report low sensitivity (41.2%) and high specificity (92.3%). They rightfully chose a threshold for notification while seeking to keep the false positive rate low.

The white paper: www.apple.com/health/pdf/H...

19.09.2025 01:15 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0

Read on if you are interested in (the Apple Watch) diagnostic test performance.

It's all about the likelihood ratios.

19.09.2025 01:15 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0

I still applaud Apple and think the Hypertension Notification feature will be useful for the individual and society. Any nudge that can help early identification of hypertension is valuable, especially when it is passively integrated into everyday use of a consumer device as implemented by Apple.

19.09.2025 01:15 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0

In other words, you should NOT rest on your laurels and assume that you don't have hypertension. Get your blood pressure tested regularly regardless, because hypertension is very common, deadly in the long term, and highly treatable.

19.09.2025 01:15 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0

If you do NOT get a Hypertension Notification despite using your watch, then you are NO MORE LIKELY to be free of hypertension than before you used your watch (inverse negative likelihood ratio 1.6, which is inconclusive).

19.09.2025 01:15 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0
Post image

If you get an Apple Watch Hypertension Notification, then you are 5 TIMES MORE LIKELY to have hypertension than if you didn't use your watch (LR+ 5.4). This is moderately useful test information. You should definitely get your blood pressure tested.

A thread..

#CardioSky
#MedSky
#Apple
#AppleWatch

19.09.2025 01:15 โ€” ๐Ÿ‘ 2    ๐Ÿ” 0    ๐Ÿ’ฌ 2    ๐Ÿ“Œ 0

Very much so, in a way that has surprised me. We are currently studying this prospectively.

13.09.2025 19:17 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
Advanced electrocardiography heart age: a prognostic, explainable machine learning approach applicable to sinus and non-sinus rhythms - PubMed An explainable A-ECG Heart Age gap applicable to both sinus and non-sinus rhythm associates with cardiovascular risk, cardiovascular morbidity, and survival.

Not at all. I rather like the approach, which can be done without compromising scientific rigor, as in the following paper from our group.

PubMed.gov/39846063

13.09.2025 08:55 โ€” ๐Ÿ‘ 1    ๐Ÿ” 0    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0
Mentor โ€“ senior person that broadly knows your field and gives you specific advice

Coach โ€“ does not need to know your field, and asks you questions to help you guide yourself to do what you want to do, without necessarily giving you specific advice

Supervisor โ€“ the person you report to and are accountable to in your work, dependency relationship

Boss โ€“ is often the Supervisor, but may be one or more steps up in hierarchy, the one who hires and fires and pays your salary

Role model โ€“ someone you look to for inspiration and wish to emulate

Advocate โ€“ promotes you and your interests, perhaps by praising your work in a meeting

Sponsor โ€“ actively invests in your growth, perhaps by using their influence to provide opportunities for advancement even when you are not in the room

Mentor โ€“ senior person that broadly knows your field and gives you specific advice Coach โ€“ does not need to know your field, and asks you questions to help you guide yourself to do what you want to do, without necessarily giving you specific advice Supervisor โ€“ the person you report to and are accountable to in your work, dependency relationship Boss โ€“ is often the Supervisor, but may be one or more steps up in hierarchy, the one who hires and fires and pays your salary Role model โ€“ someone you look to for inspiration and wish to emulate Advocate โ€“ promotes you and your interests, perhaps by praising your work in a meeting Sponsor โ€“ actively invests in your growth, perhaps by using their influence to provide opportunities for advancement even when you are not in the room

Different roles, often overlapping, all there hopefully to help.

#mentor
#coach
#supervisor
#boss
#rolemodel
#advocate
#sponsor

#MedSky
#AcademicSky
#mentorship

27.08.2025 08:25 โ€” ๐Ÿ‘ 4    ๐Ÿ” 0    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0

In our experience, "accelerated aging" measured in years of healthy human aging is a unit of measurement that has unsurpassed clarity of understanding among the general public (patients). We need to be more 'tabloid' to get our message across, imho.

22.08.2025 06:19 โ€” ๐Ÿ‘ 1    ๐Ÿ” 0    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0
Post image

John Greenwood bringing it home on #WhyCMR vs #CVnuc for myocardial perfusion imaging. #CardioSky

15.08.2025 06:58 โ€” ๐Ÿ‘ 2    ๐Ÿ” 1    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

#CardioSky #WhyCMR #EchoFirst

14.08.2025 06:45 โ€” ๐Ÿ‘ 1    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

Imaging of aortic regurgitation presented eloquently by @JoaoLCavalcante #CSANZ2025
๐Ÿคpoor agreement b/t echo & CMR
๐Ÿ’ฐbig price to pay when AR labelled moderate
๐Ÿงฒuse CMR to accurately assess AR

#ANZCMR #whyCMR @scmrorg.bsky.social

14.08.2025 01:24 โ€” ๐Ÿ‘ 2    ๐Ÿ” 2    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0
Post image

Thursday #CSANZ2025 is packed with so many great meetings! Iโ€™ll be going between the imaging, heart failure and genetics meetings. Which one will you attend? @anastasiasmihaili.bsky.social @mugander.bsky.social

10.08.2025 21:51 โ€” ๐Ÿ‘ 4    ๐Ÿ” 3    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0

We donโ€™t yet have definitive data on it, but the non-LAVI (c) formula is likely best for short-term changes in PAWP, whereas (b) is just as good in stable hemodynamics, and (a) is good enough if you havenโ€™t acquired PV velocities.

20.07.2025 12:47 โ€” ๐Ÿ‘ 1    ๐Ÿ” 0    ๐Ÿ’ฌ 2    ๐Ÿ“Œ 0

We have actually have three formulas for estimating PAWP.
From Lindow 2024 using:
a) E + LAVI
b) E + PVs + LAVI
and from Lindow 2025 using
c) E + PVs + PVd
Their accuracy, precision and prognostic association are presented in each paper.

20.07.2025 12:47 โ€” ๐Ÿ‘ 1    ๐Ÿ” 0    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0
Preview
Echocardiography can accurately estimate pulmonary artery wedge pressure without left atrial volume informationโ€”diagnostic and prognostic performance AbstractAims. A quantitative estimate of pulmonary artery wedge pressure (PAWP) can be obtained using echocardiography, but including left atrial (LA) volu

Both HFpEF and HFrEF were included. However, it was limited to those with at most mild mitral regurgitation or stenosis, and sinus rhythm.

More details are in the paper.

academic.oup.com/ehjimp/artic...

05.07.2025 16:13 โ€” ๐Ÿ‘ 2    ๐Ÿ” 0    ๐Ÿ’ฌ 2    ๐Ÿ“Œ 0
The four fallacies of (dis)loyalty between you and an organization, and vice versa. Created by martin@ugander.com

The four fallacies of (dis)loyalty between you and an organization, and vice versa. Created by martin@ugander.com

Beware the Four Fallacies of (Dis)Loyalty.

In providing career guidance, mentoring and coaching to academics, aspects of loyalty and holding grudges (disloyalty) often come up. This has provided structure to some of these conversations.

#AcademicSky
#PhDSky
#LeadershipSky
#MentorSky
#CoachSky

22.06.2025 00:16 โ€” ๐Ÿ‘ 15    ๐Ÿ” 6    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0
Preview
Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in Obesity-Related Heart Failure: SUMMIT CMR Substudy

Tirzepatide reduces LV mass and paracardiac adipose tissue, a potential mechanism for reduced HF events in SUMMIT @jaccjournals.bsky.social @chriskramermd.bsky.social www.jacc.org/doi/10.1016/...

18.06.2025 12:59 โ€” ๐Ÿ‘ 2    ๐Ÿ” 3    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 1

Our latest work, led by Thomas Lindow, on estimating wedge pressure by #EchoFirst. #Cardiosky

LA volume is not necessarily needed. LA inflow (PVs, PVd) and outflow (E) velocities, which are proportional to pressure gradients, perform just as well.

A multi-institutional collaborative effort ๐Ÿ‡ฆ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ช

14.06.2025 05:02 โ€” ๐Ÿ‘ 4    ๐Ÿ” 5    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 1

Elegant TTE color Doppler visualization of what looks to me like blood flow between aortic root and left atrium.

09.06.2025 01:47 โ€” ๐Ÿ‘ 2    ๐Ÿ” 2    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0
Post image

#EHJCVI ๐Ÿ”Ž Whatโ€™s the link between ECV, scar burden, myocyte volume, and diastolic dysfunction in moderate AR? #whyCMR shows these parameters increase with worsening diastolic dysfunction ๐Ÿ“‰โ€ŒIs there an association with mortality? Read more ๐Ÿ‘‰ doi.org/10.1093/ehjc... #CardioSky @jgrapsa.bsky.social

03.06.2025 21:14 โ€” ๐Ÿ‘ 0    ๐Ÿ” 3    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Post image Post image Post image

Accuracy of LV mechanical dyssynchrony indices for mechanical characteristics of left bundle branch block using #WhyCMR feature tracking

academic.oup.com/ehjcimaging/...
@sarahmoharem.bsky.social @purviparwani.bsky.social @vassv.bsky.social

07.12.2024 21:19 โ€” ๐Ÿ‘ 3    ๐Ÿ” 3    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Post image

Prognostic Relevance & Lower Limit of Reference Range of LV GLS: Clinical Validation Study

#CardioSky #JACCIMG
www.jacc.org/doi/10.1016/...
@docstrom.bsky.social @davidwienermd.bsky.social @jgrapsa.bsky.social @vietheartpa.bsky.social @anastasiasmihaili.bsky.social @jaccjournals.bsky.social

21.05.2025 01:38 โ€” ๐Ÿ‘ 4    ๐Ÿ” 6    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

@mugander is following 20 prominent accounts